SCHEMBL24802434

SCHEMBL24802434

COc1ccc(C)cc1CC(=O)N(C)C

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPK8 P45983 1/20 0.48
HSD17B10 Q99714 1/20 0.47
SLC13A5 Q86YT5 1/20 0.47
POLB P06746 1/20 0.47
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
ALDH1A1 P00352 2/20 0.44
ACHE P22303 1/20 0.44
HTT P42858 1/20 0.44
CYP3A4 P08684 3/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C19 P33261 1/20 0.43
TSHR P16473 1/20 0.43
CTNNB1 P35222 1/20 0.42
WNT3A P56704 1/20 0.42
ABL1 P00519 1/20 0.42
RIN1 Q13671 1/20 0.42
EPHX2 P34913 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24802459 0.87 MEN1 (0.45) SLC13A5POLBMEN1KMT2AALDH1A1
SCHEMBL30148721 0.84 HSD17B10 (0.47) HSD17B10POLBMEN1KMT2AALDH1A1
SCHEMBL3873628 0.83 POLB (0.49) HSD17B10POLBMEN1KMT2AALDH1A1
SCHEMBL24802582 0.83 POLB (0.63) HSD17B10POLBMEN1KMT2AALDH1A1
SCHEMBL13205866 0.81 HSD17B10 (0.70) MAPK8HSD17B10SLC13A5ALDH1A1ACHE
SCHEMBL29773177 0.81 HSD17B10 (0.70) MAPK8HSD17B10SLC13A5ALDH1A1ACHE
Hydrochloric Acid SCHEMBL30772166 0.81 GAA (0.47) HSD17B10POLBMEN1KMT2AALDH1A1
SCHEMBL30148642 0.81 HSD17B10 (0.46) HSD17B10POLBMEN1KMT2AALDH1A1
SCHEMBL23616869 0.81 MAPK8 (0.48) MAPK8HSD17B10SLC13A5MEN1KMT2A
SCHEMBL24802505 0.80 HSD17B10 (0.44) HSD17B10POLBMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022268209-A1 DERIVATIVE HAVING PYRIMIDINE-FUSED CYCLIC STRUCTURE, AND USE THEREOF 四川汇宇制药股份有限公司 2022-12-29 WO disclosed